Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this research study is to examine the effects of two commonly used anesthetic drugs, dexmedetomidine and ketamine, have on the shape and muscle tone of the upper airway in children, adolescents, and young adults.
The results of this study will help in making the best decisions regarding the anesthesia medications used for sedation outside of the operating room.
Upper airway obstruction is a common problem in spontaneously breathing patients under anesthesia. This study is examining the effects of combining dexmedetomidine and ketamine on the muscle tone and airway configuration in children under anesthesia. The hypothesis is adding ketamine to dexmedetomidine will not significantly reduce airway caliber or morphology when compared to previously collected data using dexmedetomidine alone.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Anesthesia for MRI | Other | All patients will receive the same drugs. A loading dose of dexmedetomidine of 2 mcg/kg/h over ten minutes followed by a continuous infusion of 2 mcg/kg/h. Bolus dose 2 mg/kg of ketamine will be given after the initial set of research images have been taken. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dexmedetomidine | Drug | 2 mc/kg/h over ten minutes followed by a continuous infusion of 2 mcg/kg/h |
|
| Measure | Description | Time Frame |
|---|---|---|
| Measurement of soft palate under anesthesia | MRI images for research will be taken 4 times during the MRI; estimated additional 6 minutes will be added to the MRI scan | Participants will be followed for the duration of the procedure; estimated 60 - 120 minutes |
| Measurement of base of tongue under anesthesia | MRI images for research will be taken 4 times during the MRI; estimated additional 6 minutes will be added to the MRI scan | Participants will be followed for the duration of the procedure; estimated 60 - 120 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Anteroposterior dimension and transverse dimension of soft palate | MRI images for research will be taken 4 times during the MRI; estimated additional 6 minutes will be added to the MRI scan | Participants will be followed for the duration of the procedure; estimated 60 - 120 minutes |
| Anteroposterior dimension and transverse dimension of base of tongue |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mohamed Mahmoud, MD | Children's Hospital Medical Center, Cincinnati | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | United States |
Not provided
| ID | Term |
|---|---|
| D020927 | Dexmedetomidine |
| D007649 | Ketamine |
| ID | Term |
|---|---|
| D007093 | Imidazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Ketamine | Drug | Bolus dose 2 mg/kg after first set of research images are obtained |
|
MRI images for research will be taken 4 times during the MRI; estimated additional 6 minutes will be added to the MRI scan |
| Participants will be followed for the duration of the procedure; estimated 60 - 120 minutes |
| Patient movement during MRI | Participants will be followed for the duration of the procedure; estimated 60 - 120 minutes |
| Episodes of low oxygen saturation | Participants will be followed for the duration of the procedure; estimated 60 - 120 minutes |
| Placement of adjunct airway | Participants will be followed for the duration of the procedure; estimated 60 - 120 minutes |
| Arterial blood pressure relative to baseline before dexmedetomidine is given | Participants will be followed for the duration of the procedure; estimated 60 - 120 minutes |
| Heart rate relative to baseline before dexmedetomidine is given | Participants will be followed for the duration of the procedure; estimated 60 - 120 minutes |
| D003510 |
| Cyclohexanes |
| D003516 | Cycloparaffins |
| D006840 | Hydrocarbons, Alicyclic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D009930 | Organic Chemicals |